SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 344 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,523,771 | -15.3% | 78,566 | -19.9% | 0.05% | -10.7% |
| Q2 2023 | $11,239,336 | -31.9% | 98,143 | -18.0% | 0.06% | -37.1% |
| Q1 2023 | $16,493,565 | +9.4% | 119,666 | +2.9% | 0.09% | +2.3% |
| Q4 2022 | $15,069,636 | -13.6% | 116,296 | -26.3% | 0.09% | -23.7% |
| Q3 2022 | $17,436,000 | +1204.1% | 157,731 | +784.1% | 0.11% | +1325.0% |
| Q2 2022 | $1,337,000 | +246.4% | 17,841 | +244.2% | 0.01% | +300.0% |
| Q1 2021 | $386,000 | -69.6% | 5,184 | -30.5% | 0.00% | -75.0% |
| Q4 2020 | $1,271,000 | +6.5% | 7,456 | -12.3% | 0.01% | 0.0% |
| Q3 2020 | $1,193,000 | +377.2% | 8,497 | +448.2% | 0.01% | +700.0% |
| Q3 2018 | $250,000 | – | 1,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |